These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 14832411)

  • 1. The virulence of Haemophilus pertussis for mice by the intranasal route.
    STANDFAST AF
    J Gen Microbiol; 1951 May; 5(2):250-66. PubMed ID: 14832411
    [No Abstract]   [Full Text] [Related]  

  • 2. The comparison between field trials and mouse protection tests against intranasal and intracerebral challenges with Bordetella pertussis.
    STANDFAST AF
    Immunology; 1958 Apr; 1(2):135-43. PubMed ID: 13538530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on Hemophilus pertussis (Bordet-Gengou). IV. Studies on antigenicity, virulence and toxicity].
    BILLAUDELLE H
    Acta Pathol Microbiol Scand; 1955; 37(5):441-8. PubMed ID: 13301722
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of virulence on the immunising potency for mice of Haemophilus pertussis, phase I.
    GRAY DF
    J Pathol Bacteriol; 1947; 59(1-2):235-46. PubMed ID: 20266365
    [No Abstract]   [Full Text] [Related]  

  • 5. Some factors influencing the virulence for mice of Bordetella pertussis by the intracerebral route.
    STANDFAST AF
    Immunology; 1958 Apr; 1(2):123-34. PubMed ID: 13538529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The active immunization of mice against an intracerebral infection of Haemophilus pertussis organisms by intranasal instillation of H. pertussis antigens.
    BROWN AM
    J Gen Microbiol; 1953 Feb; 8(1):iii. PubMed ID: 13035052
    [No Abstract]   [Full Text] [Related]  

  • 7. Active immunity in mice following the intranasal injection of sublethal doses of living Haemophilus pertussis.
    COOPER GN
    J Pathol Bacteriol; 1952 Jan; 64(1):65-74. PubMed ID: 14908789
    [No Abstract]   [Full Text] [Related]  

  • 8. The preparation of highly potent endotoxin of Hemophilus pertussis.
    SMOLENS J; FLAVELL EH
    J Immunol; 1947 Oct; 57(2):173-7. PubMed ID: 20266866
    [No Abstract]   [Full Text] [Related]  

  • 9. Homologous and heterologous protection after single intranasal administration of live attenuated recombinant Bordetella pertussis.
    Mielcarek N; Riveau G; Remoué F; Antoine R; Capron A; Locht C
    Nat Biotechnol; 1998 May; 16(5):454-7. PubMed ID: 9592394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice are protected against Bordetella pertussis infection by intra-nasal immunization with filamentous haemagglutinin.
    Cahill ES; O'Hagan DT; Illum L; Redhead K
    FEMS Microbiol Lett; 1993 Mar; 107(2-3):211-6. PubMed ID: 8472903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The altered reactivity of mice after immunization with Hemophilus pertussis vaccine.
    KIND LS
    J Immunol; 1953 Apr; 70(4):411-20. PubMed ID: 13035134
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice.
    Orr B; Douce G; Baillie S; Parton R; Coote J
    Vaccine; 2007 Jan; 25(1):64-71. PubMed ID: 16916566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth idiosyncrasies of some Bordetella pertussis strains, and the intracerebral virulence of these strains in mice.
    BROWN AM
    J Gen Microbiol; 1959 Jun; 20(3):532-9. PubMed ID: 13664900
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on Hemophilus pertussis (Bordet-Gengou). I. Trials for preservation or recovery of the virulence in Hemophilus pertussis].
    BILLAUDELLE H
    Acta Pathol Microbiol Scand; 1954; 35(5):458-68. PubMed ID: 13206784
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemolysis in rosettes by Hemophilus pertussis and Hemophilus parapertussis cultured on Bordet-Gengou medium].
    BERTOYE A; COURTIEU AL; GILLY R
    Ann Inst Pasteur (Paris); 1954 Oct; 87(4):469-70. PubMed ID: 13218388
    [No Abstract]   [Full Text] [Related]  

  • 16. [Studies of the reaction of the living body to pertussis vaccine, with special reference to electromyographic experiments with the intercostal muscles. II. Electromyogram of the intercostal muscles by inoculation with Hemophilus pertussis type I and Hemophilus pertussis toxin after Hemophilus pertussis vaccination].
    KURODA I
    Paediatr Jpn; 1961 Jun; 65():643-8. PubMed ID: 13755302
    [No Abstract]   [Full Text] [Related]  

  • 17. A selective medium for the primary isolation of Haemophilus pertussis and Haemophilus para-pertussis.
    NICHOLSON DE; TURNER GC
    J Gen Microbiol; 1954 Aug; 11(1):91-3. PubMed ID: 13192306
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of nontypeable Haemophilus influenzae HtrA by recombinant Bordetella pertussis with the use of filamentous hemagglutinin as a carrier.
    Alonso S; Willery E; Renauld-Mongénie G; Locht C
    Infect Immun; 2005 Jul; 73(7):4295-301. PubMed ID: 15972522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on protection against experimental tularemia in mice. I. Altered susceptibility of white mice to tularemia following Hemophilus pertussis vaccination.
    PANNELL L
    J Infect Dis; 1958; 102(2):162-6. PubMed ID: 13525775
    [No Abstract]   [Full Text] [Related]  

  • 20. Histamine shock in mice sensitized with Hemophilus pertussis vaccine.
    PARFENTJEV IA; GOODLINE MA
    J Pharmacol Exp Ther; 1948 Apr; 92(4):411-3. PubMed ID: 18911838
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.